Stilla Technologies completes €16 Million Series A
Novel digital PCR system
Stilla Technologies, provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures, with participation from Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds & Idinvest Partners. As part of the financing, Nick Naclerio (Illumina Ventures), Philippe Peltier (Kurma Partners) and Philippe Chambon (LBO France) have joined the board of directors, replacing the seed investors.
Since 2016, Stilla Technologies has been providing research organizations specialized in molecular biology and genetic analysis with its Naica System, a ground-breaking digital PCR solution that enables scientists to detect and quantify DNA mutations with unrivalled precision.
“With our Naica System, researchers worldwide are building a new generation of high-precision genetic tests, in various fields of applications such as liquid biopsy tests for cancer diagnostics, pre-natal testing or GMO detection” commented Rémi Dangla, CEO and co-founder of Stilla Technologies.”The additional financing will enable Stilla to accelerate the sales of the Naica System, , launch our 2nd generation solution, and begin clinically validating panels to be run on the system with an initial focus in the field of oncology.”
“We are very excited to be working with Stilla and such a deep syndicate of European investors added Nick Naclerio, Founding Partner of Illumina Ventures. “The Stilla team has done an amazing job developing and launching the Naica system in Europe and Asia with a very limited amount of seed financing. With these additional resources, we believe that Stilla Technologies can become a global leader in digital PCR and the lowest cost platform for liquid biopsies.”
Other news from the department business & finance
These products might interest you
CFX Opus by Bio-Rad Laboratories
Modern qPCR system: Calibration-free & networked
Ensure consistent results and flexible data management for gene expression analysis and GMO testing
qTOWER³ auto by Analytik Jena
Real-time PCR - fully automated for maximum efficiency
Compact, reliable and cost-effective qPCR thermal cycler for high throughput
qTOWER iris by Analytik Jena
Real-time PCR thermal cycler qTOWER iris
Feel Free to Explore!
Biometra TAdvanced by Analytik Jena
Biometra TAdvanced – Benefit from More Than 30 Years of Experience in PCR
A Variety of Block Modules Makes Your PCR Cycler Adaptable to Each Future Requirement
Mastercycler X50 by Eppendorf
Reproducible, flexible and fast optimization of your PCR protocols
Connect up to 50 PCR cyclers to speed up your routine tasks and increase your throughput
Naica Crystal Digital PCR System by STILLA Technologies
High sensitivity and multiplexing for DNA/RNA detection and quantification-Naica Digital PCR System
Discover the potential of Crystal Digital PCR - a sensitive, fast and user-friendly solution
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
